相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。18F-Flortanidazole Hypoxia PET Holds Promise as a Prognostic and Predictive Imaging Biomarker in a Lung Cancer Xenograft Model Treated with Metformin and Radiotherapy
Sven De Bruycker et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism
Jae Hyun Kim et al.
SCIENTIFIC REPORTS (2018)
Metformin as an Anticancer Agent
Ales Vancura et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
How to Modulate Tumor Hypoxia for Preclinical In Vivo Imaging Research
Sven De Bruycker et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2018)
Characterization of an Orthotopic Colorectal Cancer Mouse Model and Its Feasibility for Accurate Quantification in Positron Emission Tomography
Sara Rapic et al.
MOLECULAR IMAGING AND BIOLOGY (2017)
[18F]Fluoromisonidazole PET in rectal cancer
Tanuj Puri et al.
EJNMMI RESEARCH (2017)
Results from 11C-metformin-PET scans, tissue analysis and cellular drug-sensitivity assays questions the view that biguanides affects tumor respiration directly
Ane B. Iversen et al.
SCIENTIFIC REPORTS (2017)
Metformin and improved treatment outcomes in radiation therapy - A review
Nur Atiqah Binte Samsuri et al.
CANCER TREATMENT REVIEWS (2017)
The changing paradigm of tumour response to irradiation
Richard P. Hill
BRITISH JOURNAL OF RADIOLOGY (2017)
Combinational strategies of metformin and chemotherapy in cancers
Hui-Hui Zhang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial
Takuma Higurashi et al.
LANCET ONCOLOGY (2016)
Baseline [18F]FMISO μPET as a Predictive Biomarker for Response to HIF-1α Inhibition Combined with 5-FU Chemotherapy in a Human Colorectal Cancer Xenograft Model
Sven De Bruycker et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts
Matthew B. Lipner et al.
PLOS ONE (2016)
MATE2 Expression Is Associated with Cancer Cell Response to Metformin
Sanjana Chowdhury et al.
PLOS ONE (2016)
Targeting LKB1 in cancer - exposing and exploiting vulnerabilities
M. Momcilovic et al.
BRITISH JOURNAL OF CANCER (2015)
Lack of Effect of Metformin on Mammary Carcinogenesis in Nondiabetic Rat and Mouse Models
Matthew D. Thompson et al.
CANCER PREVENTION RESEARCH (2015)
Molecular Pathways: A Novel Approach to Targeting Hypoxia and Improving Radiotherapy Efficacy via Reduction in Oxygen Demand
Alexander Lin et al.
CLINICAL CANCER RESEARCH (2015)
A Comparative Study of the Hypoxia PET Tracers [18F] HX4, [18F] FAZA, and [18F] FMISO in a Preclinical Tumor Model
Sarah G. J. A. Peeters et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Metformin: A Novel Biological Modifier of Tumor Response to Radiation Therapy
Marianne Koritzinsky
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Hypoxia and Predicting Radiation Response
Richard P. Hill et al.
SEMINARS IN RADIATION ONCOLOGY (2015)
Imaging tumour hypoxia with positron emission tomography
I. N. Fleming et al.
BRITISH JOURNAL OF CANCER (2015)
Monitoring tumor proliferative response to radiotherapy using 18F-fluorothymidine in human head and neck cancer xenograft in comparison with Ki-67
Chowdhury Nusrat Fatema et al.
ANNALS OF NUCLEAR MEDICINE (2013)
Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK
Y. Storozhuk et al.
BRITISH JOURNAL OF CANCER (2013)
Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response
Vanessa E. Zannella et al.
CLINICAL CANCER RESEARCH (2013)
K-ras gene mutation as a predictor of cancer cell responsiveness to metformin
Yu Ma et al.
MOLECULAR MEDICINE REPORTS (2013)
Tumour hypoxia imaging with 18F-fluoroazomycinarabinofuranoside PET/CT in patients with locally advanced rectal cancer
Birgitte M. Havelund et al.
NUCLEAR MEDICINE COMMUNICATIONS (2013)
Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug
Cecilia Garofalo et al.
PLOS ONE (2013)
Phenformin enhances the therapeutic benefit of BRAFV600E inhibition in melanoma
Ping Yuan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Metformin Accelerates the Growth of BRAFV600E-Driven Melanoma by Upregulating VEGF-A
Matthew J. Martin et al.
CANCER DISCOVERY (2012)
Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
Michael N. Pollak
CANCER DISCOVERY (2012)
Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase
Yon Hui Kim et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ER alpha negative MDA-MB-435 breast cancer model
Kathryn N. Phoenix et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Positron emission tomography as an imaging biomarker
Wolfgang A. Weber
JOURNAL OF CLINICAL ONCOLOGY (2006)
分享论文
